• Small Molecules
    • Large Molecules
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

Our Leadership

Jonathan Hunt

Managing Director and Chief Executive Officer

Jonathan holds a BA (Business Studies & Economics) degree from the University of Sheffield, United Kingdom and has done his MBA from Durham University, United Kingdom. He is responsible for leading Syngene’s business operations as well as steering its investments in developing and strengthening its capabilities and capacities. He has more than 25 years of extensive experience in the global biopharmaceuticals industry. Prior to joining Syngene in January 2015, he worked with Astrazeneca for over a decade where he has held various leadership positions including President & Director of Astrazeneca, Austria and President & COO, Astrazeneca India.

Mahesh Bhalgat

Chief Operating Officer

Mahesh holds a Ph.D. in Medicinal Chemistry from the University of Utah, the USA, and a bachelor’s degree in Pharmacy from the University of Mumbai. He has 30 years of experience in the biopharmaceutical, vaccine and pharma industries. Mahesh has worked and led different facets of R&D, analytical development, manufacturing and operations, technology transfer, regulatory sciences, quality and capital projects. During a 20-year US stint, he worked with Amgen, Monsanto, Celera Genomics and Molecular Probes (now Thermo Fisher). After moving to India, Mahesh was part of the team that brought WHO prequalification approvals for four vaccines in Biological E. Just before joining Syngene, he was the Chief Operating Officer at Shantha Biotechnics, a Sanofi company, where his responsibilities included operations, quality, supply chain, long-term strategic planning, manufacturing science and technology and human resources. Mahesh is a member of the CII National Committee on Technology, R&D and Innovation. At Syngene, Mahesh is the Chief Operating Officer and a member of the Executive Committee.

Ashu Tandon

Chief Commercial Officer

Ashu holds a BA (Economics) degree from the University of Delhi, India as well as a Post Graduate Diploma in International Marketing from the Delhi School of Economics. He completed his MBA from IMT Ghaziabad, India and has over 20 years experience in the global biopharmaceuticals industry which includes Sales and Account Management leadership across consulting & outsourcing services in Research & Development. Ashu is based out of New Jersey and has global responsibility for Syngene’s commercial activities, including leading the business development team as well as developing new capabilities in marketing, brand building, digital & account management. As a member of the Executive Committee, he plays an important role in driving strategy as it relates to Commercial activities. Prior to joining Syngene, Ashu was at IQVIA (formerly QuintilesIMS), Infosys and Accenture.

Sibaji Biswas

Chief Financial Officer

Sibaji is a certified Chartered Financial Analyst (CFA) from ICFAI and holds a B.Tech from IIT- Kharagpur. With an MBA from University of Calcutta he has also completed Management Development Programs at Indian Institute of Management (IIM), Ahmedabad and London Business School. He has over 20 years of extensive experience in finance and related functions. His prior experience includes working with Vodafone (Romania), Vodafone (India), Hutchison Essar Limited, Fascel Limited, and the ABP Group. Prior to joining Syngene, he was the CFO and a member of the Board at Vodafone (Romania). At Syngene, he oversees the finance, supply chain, legal, secretarial and IT functions and as a member of the Executive Committee, he plays an important role in driving strategy, improving profitability, identifying new opportunities, improving cash generation and enabling organizational growth.

Sanjeev Sukumaran

Chief Human Resources Officer

Sanjeev is a Mechanical Engineer and holds a management degree from the Indian Institute of Management (IIM), Kozhikode and has done an Executive Leadership Program at INSEAD, Singapore. He has nearly 25 years of experience in the areas of strategic management, business advisory, sales and marketing, business development, client relationship management and team management across a range of sectors, including healthcare, life sciences, financial services, software and IT, FMCG, big data, supply chain management, e-commerce and shipping. Before joining Syngene, he held multiple senior-level positions at Thomson Reuters. He was also the former CEO of Force Fulcrum Solutions Pvt. Ltd. As CHRO, Sanjeev is a member of the Executive Committee (EC) and is responsible for talent acquisition, talent management, workforce management, employee value proposition, learning and development, employee engagement, rewards and recognition and succession planning.

Alok Mehrotra

Chief Quality Officer

Alok holds an M. Tech in Chemical Technology (Food Technology) from Harcourt Butler Technological Institute. He comes with more than 25 years of experience spread across Manufacturing Operations, Quality Assurance, Sustainability/EHS, Production, and Supplier Technical Assurance across varied industries. Over the years, Alok has worked with leading corporates, including Dr. Reddy’s, Reckitt Benckiser, Pepsi Foods Ltd,  Godrej Foods, and Beverages Ltd. In his recent assignment as Head of Global Quality Management at Dr. Reddy’s, he harmonized and integrated Quality management systems Globally and was also responsible for quality from all external suppliers and vendors. As Syngene’s CQO, Alok leads the Quality and Compliance function and will be in charge of initiatives to further strengthen our track record in quality and compliance

Kenneth Barr, Ph.D

Sr. Vice President – Discovery Services

Kenneth holds a Ph.D. in Synthetic Organic/Organometallic Chemistry from Massachusetts Institute of Technology and has pursued his Postdoctoral study in Natural product synthesis from the University of Texas. He has over two decades of experience in the areas of drug discovery for both small and large molecules and has been associated with organisations like Merck, Amplyx Pharmaceuticals Inc. and Sunesis. Prior to joining Syngene, Kenneth was the Head of R&D Strategic Global Operations at FORMA Therapeutics, where he was responsible for driving research effectiveness through optimisation of internal and external R&D research efforts, providing alliance management for key CRO relationships.

Jan-Olav Henck, Ph.D.

Sr. Vice President – Development Services

Jan-Olav holds a doctoral degree from the Faculty of Natural Science, Leopold-Franzens University, Innsbruck and postdoc from the Department of Chemistry, Ben-Gurion University of the Negev, Israel. He has over two decades of experience across both small and large molecule pharmaceutical development, including API and drug product work from late lead optimization to commercialization. He is also experienced in drug formulation production under cGMP conditions. His prior experience includes working with SSIC Inc and Aptuit LLC. Prior to joining Syngene, he was the Vice President and Head of Formulations Development at Bayer AG. He has over twelve research publications and several patents to his credit. As a member of the Executive Committee, he oversees the development value chain connecting upstream discovery service programs that transition into downstream development programs and support smooth transition into commercial manufacturing.

Alex Del Priore

Senior Vice President - Manufacturing

Alex has three decades of experience in developing, commercializing and life-cycle management of products in various life science industries. Holding positions in both the US and Europe, his experience includes senior roles with global P&L responsibility. Alex was Vice President Operations and Health COO at Johnson Matthey in Greater London in his last assignment. In addition, he has been instrumental in M&A, strategy development and new product introduction.

As a member of the Executive Committee, Alex plays a techno-commercial role, providing technical expertise to the API plant at Mangalore while building a sustainable client base for the business in collaboration with the commercial and business development teams. In addition, Alex is also responsible for biologics operations. Alex is based in Center Valley, Pennsylvania, USA.

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

To download, Please share your details

To download, Please share your details